GZMA and cancer: The killing of cancer cells by CD8+ T cells and NK cells purified from the same mice was also markedly reduced, and the reduced granzyme activity was reflected in the slower turnover of model peptide substrates specific to granzyme A (GzmA) and granzyme B (GzmB).